Colgate-Palmolive http://so-l.ru/tags/show/colgate_palmolive Fri, 15 Dec 2017 01:53:52 +0300 <![CDATA[Societe Generale prefers Church & Dwight to Colgate-Palmolive]]> http://so-l.ru/news/y/2017_11_29_societe_generale_prefers_church_dwight Wed, 29 Nov 2017 19:41:38 +0300 <![CDATA[Colgate-Palmolive a top pick at Morgan Stanley]]> http://so-l.ru/news/y/2017_11_14_colgate_palmolive_a_top_pick_at_morgan_s Tue, 14 Nov 2017 21:04:33 +0300 <![CDATA[Colgate-Palmolive settles lawsuit over asbestos in talc-based products]]> http://so-l.ru/news/y/2017_11_10_colgate_palmolive_settles_lawsuit_over_a Fri, 10 Nov 2017 18:38:01 +0300 <![CDATA[The Zacks Analyst Blog Highlights: AbbVie, Union Pacific, Bristol-Myers, Weyerhaeuser and Colgate]]> For Immediate Release

Chicago, IL – November 2, 2017 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include AbbVie ABBV, Union Pacific UNP, Bristol-Myers BMY, Weyerhaeuser WY and Colgate CL.

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.

Here are highlights from Wednesday’s Analyst Blog:

Top Stock Reports for AbbVie, Union Pacific and Bristol Myers

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including AbbVie, Union Pacific and Bristol-Myers. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see all of today’s research reports here >>>

AbbVie's shares have gained +44.1% year to date, outperforming the Zacks Large Cap Pharmaceuticals industry, which has gained +14.6% over the same period. AbbVie reported mixed Q3 results. While earnings beat estimates, revenues came in line. Humira and Imbruvica kept up the strong performance.

Meanwhile, AbbVie raised its earnings outlook for the year backed by a strong year-to-date performance.  Despite new competition, it raised its long-term target for Humira sales based on strong demand trends for the drug.

The Zacks analyst stresses that the past 2-3 months have been strong for the company as it presented promising data from several pivotal studies, gained regulatory approvals in the U.S., Europe, and Japan for its competitive HCV medicine Mavyret and FDA approval for the sixth indication for Imbrivica and settled its Humira patent disputes with Amgen.

Also, several pivotal data readouts and regulatory milestones are expected in 2018. However, HCV sales continue to be hurt by intensifying competition.

(You can read the full research report on AbbVie here >>>).

Shares of Buy-rated Union Pacific have outperformed the Zacks Rail Transportation Industry as well as fellow railroad operator Kansas City Southern over the last three months. While the company has gained +13.1%, the industry in belongs to and Kansas City Southern have rallied +8.3% and +2.1%, respectively, so far this year.

Ushering in further good news, Union Pacific reported better-than-expected earnings per share and revenues in the third quarter of 2017. Results were aided by strong performances of the company's intermodal and industrial products units.

The Zacks analyst is impressed by the company's efforts to cut costs to drive its bottom line as well. Efforts to reward investors also raise optimism in the stock. However, declining coal revenues in the third quarter raise concerns. Automotive volumes also decreased due to sluggish vehicle production in the United States.

(You can read the full research report on Union Pacific here >>>).

Strong Buy-rated Bristol-Myers shares have underperformed the broader market as well as the Zacks Large Cap Pharmaceuticals industry this year, gaining only +5.5% in the year-to-date period. Bristol-Myers reported mixed results for the third-quarter with earnings missed expectations although revenue beat on the same. The miss in earnings was attributable to lower gross margin which in turn was due to product mix and decline in virology business.

The Zacks analyst thinks the increase in earnings guidance is encouraging. The company’s blockbuster immuno-oncology Opdivo continues to perform well along with Eliquis and Orencia. The company is looking to expand Opdivo’s label further and recently won FDA approvals for liver and colorectal cancers which should boost performance.

The company is also looking to counter generic threat for its key drugs through deals and acquisitions. The company recently entered into a deal with AbbVie and Halozyme. However, Opdivo is currently facing competitive challenges in the United States. The virology business is also under pressure.

(You can read the full research report on Bristol-Myers here >>>).

Other noteworthy reports we are featuring today include Weyerhaeuser and Colgate.

Today's Stocks from Zacks' Hottest Strategies

It's hard to believe, even for us at Zacks. But while the market gained +18.8% from 2016 - Q1 2017, our top stock-picking screens have returned +157.0%, +128.0%, +97.8%, +94.7%, and +90.2% respectively.

And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - Q1 2017, the composite yearly average gain for these strategies has beaten the market more than 11X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation.

See Them Free>>

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1 Stock of the Day pick for free.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Strong Stocks that Should Be in the News

Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has nearly tripled the market from 1988 through 2015. Its average gain has been a stellar +26% per year.See these high-potential stocks free >>.

Follow us on Twitter: https://twitter.com/zacksresearch

Join us on Facebook: https://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

https://www.zacks.com/

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Union Pacific Corporation (UNP): Free Stock Analysis Report
 
Bristol-Myers Squibb Company (BMY): Free Stock Analysis Report
 
AbbVie Inc. (ABBV): Free Stock Analysis Report
 
Weyerhaeuser Company (WY): Free Stock Analysis Report
 
Colgate-Palmolive Company (CL): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research]]>
http://so-l.ru/news/y/2017_11_02_the_zacks_analyst_blog_highlights_abbvi Thu, 02 Nov 2017 15:27:00 +0300
<![CDATA[Субботник в Алтачейском заказнике]]> http://so-l.ru/news/y/2017_11_02_subbotnik_v_altacheyskom_zakaznike Thu, 02 Nov 2017 12:00:00 +0300 <![CDATA[Stock Market News For Oct 27, 2017]]> Markets closed mostly higher on Thursday backed by strong earnings from some prominent stocks. Both the Dow and the S&P 500 ended in the green. However, biotech stocks tanked, pulling the healthcare sector lower and weighing on the Nasdaq. Meanwhile, the House of Representatives cleared the budget blueprint with majority of the Republicans voting in favor of the move. Further, the ECB announced plans to extend the quantitative easing program.

The Dow Jones Industrial Average (DJIA) closed at 23,400.86, gaining 0.3%. The S&P 500 Index (INX) increased 0.1% to close at 2,560.40. Meanwhile, the Nasdaq Composite Index (IXIC) closed at 6,556.77, increasing 0.1%. Advancing issues outnumbered decliners on the NYSE by a 1.22-to-1 ratio. On the Nasdaq, advancers outnumbered decliners by a 1.14-to-1 ratio. The CBOE VIX decreased almost 2% to close at 11.01.

Dow, S&P 500 Continue to Gain

The Dow amassed 71.4 points on Wednesday to finish in positive territory. Gains for the blue-chip index were powered by shares of Nike NKE, which gained 3.4% after the shoe and apparel retailer raised the revenue growth target for the coming years. These announcements were made at the company’s investor day. Nike’s shares were the biggest gainers for the Dow.

The S&P 500 also ended in the green, gaining 3.3 points in the process. Of the 11 major segments of the S&P 500, nine finished in the green, with materials leading the gainers. The Materials Select Sector SPDR ETF (XLB) gained 1.3% to close at 59.43. Such gains were made possible after shares of Union Pacific Corp. UNP surged 5.6% following an earnings beat in the third quarter, 2017. Both the companies possess a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

The rail transportation provider’s third-quarter 2017 earnings of $1.50 beat the Zacks Consensus Estimate of $1.49 per share. The bottom line expanded 10.3% on a year-over-year basis. Results were aided by higher revenues. Operating revenues of $5,408 million also surpassed the Zacks Consensus Estimate of $5,306.5 million. (Read More)

Biotech Shares Weigh on the Nasdaq

Meanwhile, the Nasdaq suffered losses as it gave up 7.1 points to end in the red, just ahead of the release of earnings from some of the major tech stocks from FAAMG group such as Alphabet GOOGL, Microsoft MSFT and Amazon AMZN. Losses for the Nasdaq were incurred after the biotech shares tanked. This had negative ramifications for the overall healthcare sector as well. The iShares Nasdaq Biotechnology ETF (IBB) plummeted 2.3%, pulling the overall healthcare sector lower by 1%.

Biotech stocks suffered losses after shares of Celgene Corp. CELG tanked 16.4% despite surpassing the earnings expectations in the third quarter. The company missed out on revenue expectation on Q3 and suffered losses. Celgene reported mixed results in third-quarter 2017 wherein earnings beat expectations but sales failed to meet estimates. (Read More)

House Passes Budget Blueprint

House of Representative passed the budget blueprint on Thursday. This officially unlocked a procedure using which the tax code can be changed using a simple majority of only Republican votes, instead of the 60 votes norm usually followed. Trump and his fellow Republicans had campaigned on bringing about much needed tax reforms and such an event gets the members of GOP even closer to delivering on their promise.

In a 216 to 212 vote, the House cleared the budget blueprint, with as many as 20 Republicans voting against it. Meanwhile, House Ways & Means Committee Chairman Kevin Brad stated that the budget Bill would be introduced on Nov 1. Apart from tax repatriation, the framework also promises to almost double the standard deduction of tax rates and add as much as $1.5 trillion to deficits over a period of 10 years.

ECB Extends Quantitative Easing

The ECB announced on Thursday that it will be slashing the level of bond purchases every month, but, will extend the length of the time the stimulus program runs. ECB promised to buy €30 billion in bonds from €60 billion, beginning in January. The central bank intends to extend its monetary stimulus program until at least September 2018.

The ECB also reiterated that interest rates would remain at their current levels well past the end of the quantitative easing (QE) program.

Economic Data

Pending home sales for the month of September remained unchanged from August, whereas the consensus estimate for the period was a decline of 0.5%. With this, the index hit a two and a half year low. Such a lackluster show can be attributed to extremely short supply amidst strong demands.  Meanwhile, initial jobless claims decreased to 233,000 — still languishing at historically low levels. The consensus estimate for the period was an increase to 235,000.

Stocks That Made Headlines

Deckers Defies Retail Challenges, Tops on Q2 Earnings

It was not UGG but sturdy sales performance across HOKA ONE ONE and Teva brands coupled with lower cost of sales and SG&A expenses that enabled Deckers Outdoor Corporation DECK to post better-than-expected second-quarter fiscal 2018 results. (Read More)

Pinnacle Foods Q3 Earnings Beat, Up Y/Y, Stock Down

Pinnacle Foods Inc. PF posted third-quarter 2017 results, wherein both the top and bottom line outpaced the Zacks Consensus Estimate and the latter also grew year over year. (Read More)

Colgate Dips on Hiked Charges View, Q3 Earnings In Line

Colgate-Palmolive Co. CL posted adjusted earnings of 73 cents a share in third-quarter 2017, in line with the Zacks Consensus Estimate and flat with the prior-year quarter. (Read More)

Leggett Narrows 2017 View After Mixed Q3 Earnings

Leggett & Platt Incorporated LEG reported mixed results for third-quarter 2017. (Read More)

Wall Street’s Next Amazon

Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.

Click for details >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Union Pacific Corporation (UNP): Free Stock Analysis Report
 
Amazon.com, Inc. (AMZN): Free Stock Analysis Report
 
Alphabet Inc. (GOOGL): Free Stock Analysis Report
 
Microsoft Corporation (MSFT): Free Stock Analysis Report
 
Pinnacle Foods, Inc. (PF): Free Stock Analysis Report
 
Leggett & Platt, Incorporated (LEG): Free Stock Analysis Report
 
Celgene Corporation (CELG): Free Stock Analysis Report
 
Nike, Inc. (NKE): Free Stock Analysis Report
 
Deckers Outdoor Corporation (DECK): Free Stock Analysis Report
 
Colgate-Palmolive Company (CL): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research]]>
http://so-l.ru/news/y/2017_10_27_stock_market_news_for_oct_27_2017 Fri, 27 Oct 2017 17:13:00 +0300
<![CDATA[More on Colgate-Palmolive's Q3 results]]> http://so-l.ru/news/y/2017_10_27_more_on_colgate_palmolive_s_q3_results Fri, 27 Oct 2017 16:55:36 +0300 <![CDATA[Colgate (CL) Dips on Hiked Charges View, Q3 Earnings In Line]]> Colgate-Palmolive Co. CL posted adjusted earnings of 73 cents a share in third-quarter 2017, in line with the Zacks Consensus Estimate and flat with the prior-year quarter.
 
Including one-time items, earnings came in at 68 cents a share compared with 78 cents reported in the year-ago period.

Despite earnings beat, Colgate’s shares are down 1.4% during pre-market trading hours, as it raised guidance for charges. In fact, the stock has increased 8.8% year to date, underperforming the broader industry’s growth of 13.8%.



Deeper Insight

Total sales of $3,974 million improved 3% from the year-ago period and topped the Zacks Consensus Estimate of $3,930 million. The top line gained from 1.5% increase in unit volumes and favorable currency impact of 1.5%, alongside flat pricing from last year.

On an organic basis (excluding foreign exchange, acquisitions and divestitures), the company’s sales increased 1.5% from last year.

Adjusted gross profit margin was 60.4%, flat with the prior-year quarter. During the quarter gains from the cost-saving initiatives under the company’s funding-the-growth and 2012 Restructuring Program, were neutralized by increased raw and packaging material expenses.

In the reported quarter, adjusted operating profit of $985 million dipped 4%, with the adjusted operating margin contracting 160 basis points (bps) to 24.8%. Operating margin decline can be attributed to 140 bps rise in adjusted selling, general & administrative expenses as a percentage of sales, which included higher investments in advertising.

Year to date, Colgate’s market share of manual toothbrushes has reached 32.6%. Further, the company continued to lead with market share in the global toothpaste with a gain of 43.5% year to date.

Segment Discussion

North America net sales (20% of total sales) fell 0.5%, reflecting a 4% decline in pricing offset by 3% rise in unit volume and favorable currency impacts of 0.5%. On an organic basis, sales declined 1%.

Latin America net sales (25% of total sales) jumped 6.5% year over year gaining from 2.5% increase in pricing and 3% volume gains, as well as positive currency impact of 1%. Volume growth can mainly be attributed to increase in Brazil and the Southern Cone region. On an organic basis, sales increased 5.5%.

Europe net sales (16% of total sales) rose 5.5% year over year, due to 3% increase in unit volumes and a favorable currency impact of 4.5%, offset by 2% decline in pricing. Unit volumes gained from strength in France, Italy, Netherlands and Poland. Europe organic sales were up 1%.

Asia Pacific net sales (18% of total sales) inched up 0.5%, attributable to 0.5% positive currency impacts, while unit volume and pricing remained flat. Volumes in the quarter benefited from strength in the Greater China region and the Philippines, fully neutralized by declines in Australia and India. On an organic basis, sales for Asia Pacific were flat with last year.

Africa/Eurasia net sales (6% of total sales) inched up 0.5% year over year, fueled by 2.5% gains from both pricing and positive currency effects, partly offset by 4.5% drop in unit volumes. Volume declines in the Sub-Saharan Africa and Middle East regions, were partly offset by gains in Russia. Organic sales for Africa/Eurasia dropped 2%.

Hill’s Pet Nutrition net sales (15% of total sales) were up 2% from the year-ago quarter. During the quarter, positive impact of 1% from increase in unit volume and currency were somewhat neutralized by flat pricing. Volume gains in the United States and Western Europe were offset by fall in Japan. On an organic basis, sales rose 1%.

Other Financial Details

Colgate ended the quarter with cash and cash equivalents of $1,380 million and total debt of $6,527 million. Net cash provided by operating activities came in at $2,295 million for the nine months ended Sep 30, 2017.

Other Developments

Acknowledging the success of the Global Growth and Efficiency Program to date, the company’s board on Oct 26 approved an expansion and extension of the program through Dec 31, 2019. This will enable the company to take advantage of the incremental opportunities in the process of streamlining operations. The expansion is expected to attract cumulative after-tax charges of $1,280-$1,380 million from the program, marking an increase from the previously estimated charges of $1,120-$1,170 million. After-tax charges for 2017 are now likely to be in the range of $250-$280 million.

Additionally, the company expects after-tax savings from the program to increase to $500-$575 million, compared with $425-$475 million estimated earlier. The projected savings target a three to four year average cash payback, with an after-tax rate of return above 30%.

Outlook

Looking forward, Colgate anticipates the backdrop to remain challenging due to uncertain global markets and slowing category growth worldwide. However, the company remains on track with its brand building and productivity maximization initiatives. Consequently, the company reiterated low-single digits growth projection for both net sales and organic sales for 2017.

Including the impact of the expanded Global Growth and Efficiency Program, the company continues to expect gross margin expansion for 2017, along with mid-single digits percentage decline in GAAP earnings per share.

Excluding the restructuring charges resulting from the program and other one-time items, the company projects strong cash flow generation, gross margin expansion and higher advertising investments for 2017. Further, the company anticipates low-single digit earnings per share growth for the year, on an adjusted basis.

Zacks Rank & Key Picks

Colgate currently carries a Zacks Rank #3 (Hold). Better-ranked stocks in the consumer staples sector include Unilever Plc UL, Snyder's-Lance, Inc. LNCE and McCormick & Company, Incorporated MKC, all carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Unilever, with long-term EPS growth rate of 9.3%, has increased 36.3% year to date.

Snyder's-Lance has increased 6.7% in the last three months. Moreover, the company has to its credit a spectacular earnings history as it delivered an average positive earnings surprise of 2.1% in the past four quarters.

McCormick & Company, with long-term EPS growth rate of 9.4%, has grown 3.7% in last three months.

Wall Street’s Next Amazon

Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.

Click for details >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Unilever PLC (UL): Free Stock Analysis Report
 
McCormick & Company, Incorporated (MKC): Free Stock Analysis Report
 
Snyder's-Lance, Inc. (LNCE): Free Stock Analysis Report
 
Colgate-Palmolive Company (CL): Free Stock Analysis Report
 
To read this article on Zacks.com click here.]]>
http://so-l.ru/news/y/2017_10_27_colgate_cl_dips_on_hiked_charges_view Fri, 27 Oct 2017 15:40:00 +0300
<![CDATA[Colgate (CL) Q3 Earnings in Line, Sales Beat, Stock Down]]> Colgate-Palmolive Company CL, a global dealer in consumer goods, came out with third-quarter 2017 adjusted earnings of 73 cents per share, which came in line with Zacks Consensus Estimate and remained flat year over year.

For 2017, the company reiterated its adjusted earnings per share to grow at a low-single-digit range on a year over year basis. However, GAAP earnings per share are still expected to drop at a mid single-digit rate.

Earnings Estimate Revision: The Zacks Consensus Estimate for 2017 has moved up by a penny in the past 30 days. Further, if we look at Colgate’s performance in the trailing four quarters (excluding the quarter under review), the company has outperformed the Zacks Consensus Estimate by an average of 0.4%.

Revenues: Colgate’s sales increased 3% to $3,974 million during the quarter, owing to 1.5% growth from both, volumes and favorable currency impact. However, pricing remained flat with the prior-year period. Organic sales rose 1.5% in the quarter. Notably, sales topped the Zacks Consensus Estimate of $3,930 million, thus breaking its long dismal surprise trend.

Depending upon the current spot rates, management continues to anticipate both, net sales and organic sales for 2017 to rise in low-single-digits.

Zacks Rank: Currently, Colgate carries a Zacks Rank #3 (Hold), which is subject to change based on the just released earnings results.

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Stock Movement: Colgate’s shares dipped nearly 1.9% during pre-market trading hours following the earnings release.

Check back later for our full write up on Colgate’s earnings report!

Wall Street’s Next Amazon

Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.

Click for details >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Colgate-Palmolive Company (CL): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research]]>
http://so-l.ru/news/y/2017_10_27_colgate_cl_q3_earnings_in_line_sales Fri, 27 Oct 2017 15:38:00 +0300
<![CDATA[Квартальные продажи Colgate-Palmolive выросли на 3% г/г]]> http://so-l.ru/news/y/2017_10_27_kvartalnie_prodazhi_colgate_palmolive_vi Fri, 27 Oct 2017 15:16:00 +0300 <![CDATA[Colgate-Palmolive EPS in-line, beats on revenue]]> http://so-l.ru/news/y/2017_10_27_colgate_palmolive_eps_in_line_beats_on Fri, 27 Oct 2017 13:55:57 +0300 <![CDATA[Must-Watch Earnings Charts to End the Week]]>

This is a big week for earnings, with over 800 companies expected to report, including many Dow Industrial and S&P 500 companies.

In addition to some of the top technology titans, there are also a handful of other companies that you should keep an eye on.

These companies are on everyone’s list because they are breaking out, are widely held, or they just have fantastic earnings track records.

It’s not easy to beat the earnings consensus every quarter for years, but some of these companies are doing just that.

5 Earnings Reports You Must Watch

1.    Baidu BIDU hasn’t missed since 2014. Shares had been stuck in a narrow trading range but have recently busted out to new 5-year highs. Can it build even more momentum off another earnings beat?

2.    AbbVie ABBV has missed only once since its 2013 spin-off from Abbott Labs. Shares have soared in 2017 but the healthcare stocks are out of favor. Can it continue to hit new highs?

3.    Expedia EXPE has missed 4 quarters in a row but shares are still trading near 5-year highs. Does the miss or the beat matter with this company?

4.    Colgate-Palmolive CL has only missed once in the last 5 years but shares aren’t going anywhere as the consumer products companies remain out of favor.

5.    Columbia Sportswear COLM is in the dreaded retail sector so shares have been stuck. But it has a great earnings track record, with just one miss in the last 5 years.

 

Want to Learn How to Trade Options?

Have you always wanted to trade stock options but are unsure where to begin or what to look for?

Each week, Zacks’ Dave Bartosiak will bring you a detailed explanation of the trades “live” on YouTube.

Watch him go through the trade as he answers your questions in real time.

Become one of Dave’s minions. Join the Zacks Live Trader community today.  It’s free!

Click here to join Dave >>>

More Stock News: This Is Bigger than the iPhone!

It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.

Click here for the 6 trades >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Expedia, Inc. (EXPE): Free Stock Analysis Report
 
Baidu, Inc. (BIDU): Free Stock Analysis Report
 
AbbVie Inc. (ABBV): Free Stock Analysis Report
 
Colgate-Palmolive Company (CL): Free Stock Analysis Report
 
Columbia Sportswear Company (COLM): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research]]>
http://so-l.ru/news/y/2017_10_26_must_watch_earnings_charts_to_end_the_we Thu, 26 Oct 2017 22:51:00 +0300
<![CDATA[What To Expect From Colgate-Palmolive's Q3 Earnings]]> http://so-l.ru/news/y/2017_10_26_what_to_expect_from_colgate_palmolive_ap Thu, 26 Oct 2017 19:44:00 +0300 <![CDATA[Pinnacle Foods (PF) Q3 Earnings Likely to Rise: Here's Why]]> Pinnacle Foods Inc. PF is slated to report third-quarter 2017 results before the opening bell on Oct 26. The question lingering in investors’ minds is, whether this manufacturer and distributor of branded food products will be able to maintain its positive earnings surprise streak in the to-be-reported quarter. Notably, the company has outpaced the Zacks Consensus Estimate in three of the trailing four quarters with an average beat of 3.1%.

Let’s delve deeper how things are shaping up for this announcement.

What to Expect?

Let’s look at earnings estimate revisions in order to get a clear picture of what analysts are thinking about the company right before the earnings release. The Zacks Consensus Estimate for the quarter under review has been stable at 58 cents in the last 30 days. However, the estimate reflects a year-over-year growth of about 9% from the year-ago quarter.

Further, analysts polled by Zacks expect revenues of $751 million, down more than 1% from the prior-year period.

Markedly, Pinnacle Foods is part of the Consumer Staples sector. As of Oct 20 Earnings Preview, the Consumer Staples sector’s earnings as well as revenues are expected to grow 1.8% each.

Factors Likely to Influence the Quarter

Pinnacle Foods has been gaining from its solid brand portfolio and robust strategic initiatives. The company has been also innovating products to offer variety and maintain market share. Additionally, the company’s expansion via acquisitions drives growth and remains impressive. The notable acquisitions include Boulder Brands and Duncan Hines.

Meanwhile, Pinnacle Foods’ operational excellence program designed to generate annual productivity savings across the supply chain, remains encouraging. Productivity for 2017 is estimated to be at the top or marginally above its cost of products sold range of 3.5–4%. These productivity savings, along with higher pricing have been mitigating the impact of input cost inflation to drive gross margins.

Additionally, in order to enhance gross margin, Pinnacle Foods is pursuing other initiatives including improving its product mix through product innovation and low-margin SKU rationalization, increasing the effectiveness of trade promotional spending, and realizing synergies from acquisitions.



These initiatives are reflected in the company’s share price, which increased 4.8% year to date, as against the industry’s decline of 10.3%.

Further, the Zacks Consensus Estimate for third-quarter revenues of the Frozen, Grocery and Specialty Foods segments are currently pegged at $315 million, $259 million and $84 million, respectively. These estimates show a year-over-year increase of about 2%, 3.8% and 5.8% for each segment, correspondingly.

Also, volume for the Frozen and Grocery segments is likely to increase 0.04% and 0.01%, respectively, in the quarter. However, volumes are expected to decline 0.04% for the Specialty Foods segment.
 
We note that Pinnacle Foods has been witnessing sluggish net sales and adjusted EBIT for its Specialty segment since four consecutive quarters now, despite solid growth in the Snacks business. Evidently, sales at the segment declined 15.1% in the previous quarter.

Meanwhile, the company has witnessed sluggishness in its Pickle business due to continued competitive environment in the form of pricing and innovation. This, in turn has put pressure on the performance of Vlasic pickles. Though innovation and in-store support for the brand is expected to strengthen trends for the business in the second half of 2017, the turnaround might take some time.

What the Zacks Model Unveils?

Our proven model shows that Pinnacle Foods is likely to beat earnings estimates this quarter. This is because a stock needs to have both a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) and a positive Earnings ESP for this to happen. You may uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

Pinnacle Foods, Inc. Price, Consensus and EPS Surprise

Pinnacle Foods, Inc. Price, Consensus and EPS Surprise | Pinnacle Foods, Inc. Quote

Pinnacle Foods has an Earnings ESP of +2.03%. Also, it carries a Zacks Rank #2, which makes us confident of an earnings beat.

Stocks With Favorable Combination

Here are some companies you may want to consider as our model shows that these have the right combination of elements to post an earnings beat:

Avon Products, Inc. AVP has an Earnings ESP of +2.94% and carries a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.

Colgate-Palmolive Company CL has an Earnings ESP of +0.50% and a Zacks Rank #2.

The Estee Lauder Companies Inc. EL has an Earnings ESP of +0.34% and a Zacks Rank #2

Will You Make a Fortune on the Shift to Electric Cars?
 
Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.

With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.

It's not the one you think.

See This Ticker Free >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Avon Products, Inc. (AVP): Free Stock Analysis Report
 
Estee Lauder Companies, Inc. (The) (EL): Free Stock Analysis Report
 
Pinnacle Foods, Inc. (PF): Free Stock Analysis Report
 
Colgate-Palmolive Company (CL): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research]]>
http://so-l.ru/news/y/2017_10_23_pinnacle_foods_pf_q3_earnings_likely_t Mon, 23 Oct 2017 17:42:00 +0300
<![CDATA[Here's What You Must Know Ahead of FEMSA (FMX) Q3 Earnings]]> Fomento Economico Mexicano, S.A.B. de C.V. FMX or FEMSA is slated to report third-quarter 2017 results on Oct 26, after the closing bell.

The company’s earnings have missed the Zacks Consensus Estimate in each of the trailing four quarters, with an average of 19.4%. Therefore, the question lingering in investors’ minds now is, whether FEMSA will be able to deliver positive earnings surprise in the quarter to be reported.

What to Expect?

The Zacks Consensus Estimate for the quarter under review is pegged at $1.27, which has moved up by 6 cents in the last 30 days. Additionally, analysts polled by Zacks expect revenues of $6,359 million, representing growth of more than 18% from the year-ago quarter.

Notably, FEMSA forms part of the Consumer Staples sector. As of Oct 20 Earnings Preview, the Consumer Staples sector’s earnings and revenues are expected to grow 1.8% each.

Factors Likely to Impact the Quarter

FEMSA has been grappling with soft margins for more than a year now. This can be attributed to strained margins at Coca-Cola FEMSA and growth of lower-margin businesses at FEMSA Comercio. Additionally, higher operating expenses at Coca-Cola FEMSA and FEMSA Comercio’s Health division weighed upon the company’s operating margin in the last reported quarter. Also, operating margin declined across all of the company’s segments in second-quarter 2017, barring FEMSA Comercio’s Retail division. In fact, margins were hurt by the consolidation of Coca-Cola FEMSA’s results in the Philippines as well.

Further, FEMSA has been facing difficult times due to currency headwinds, which has been weighing on Coca-Cola FEMSA’s results for a while now. We believe the continuation of these trends will impact the future results.

Consequently, FEMSA’s shares have lost 11.7% in the past three months, wider than the industry’s decline of 1.2%.



While these factors pose concern about the company’s upcoming performance, we remain impressed with FEMSA’s focus on strategic measures. These measures include increasing store count, diversifying business portfolio and focusing on core business activities. Evidently, FEMSA has been taking prudent steps to diversify its product portfolio while expanding in the small-box retail segment, which bodes well for future operating performance.

Moreover, the company’s focus on achieving growth via acquisitions bode well. Furthermore, its exposure in various industries including beverage, beer and retail, gives FEMSA an edge over competitors. In fact, the company’s strong cash flow generation capacity enables it to make incremental investments in business expansion.

So, let’s see if FEMSA’s upcoming quarterly performance can help it break the dismal earnings surprise trend backed by its strategic endeavors.

What the Zacks Model Unveils?

Our proven model does not show that FEMSA is likely to beat estimates this quarter. This is because a stock needs to have both a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for this to happen. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

FEMSA has an Earnings ESP of 0.00% as both the Most Accurate estimate and the Zacks Consensus Estimate are currently pegged at $1.27, which when combined with its Zacks Rank #5 (Strong Sell) lowers the chances of an earnings beat.

As it is we caution against stocks with a Zacks Rank #4 or 5 (Sell rated) going into the earnings announcement, especially when the company is seeing negative estimate revisions.

Stocks With Favorable Combination

Here are some companies you may want to consider as our model shows that these have the right combination of elements to post an earnings beat:

Avon Products, Inc. AVP has an Earnings ESP of +2.94% and carries a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.

Colgate-Palmolive Company CL has an Earnings ESP of +0.50% and a Zacks Rank #2.

The Estee Lauder Companies Inc. EL has an Earnings ESP of +0.34% and a Zacks Rank #2

Will You Make a Fortune on the Shift to Electric Cars?
 
Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.

With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.

It's not the one you think.

See This Ticker Free >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Fomento Economico Mexicano S.A.B. de C.V. (FMX): Free Stock Analysis Report
 
Avon Products, Inc. (AVP): Free Stock Analysis Report
 
Estee Lauder Companies, Inc. (The) (EL): Free Stock Analysis Report
 
Colgate-Palmolive Company (CL): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research]]>
http://so-l.ru/news/y/2017_10_23_here_s_what_you_must_know_ahead_of_femsa Mon, 23 Oct 2017 17:20:00 +0300
<![CDATA[Is a Beat in the Cards for SUPERVALU (SVU) in Q2 Earnings?]]> SUPERVALU INC. SVU is scheduled to report second-quarter fiscal 2018 results on Oct 18, before the market opens.

The question lingering in investors’ minds is, whether this leading grocery dealer will be able to deliver positive earnings surprise in the to-be-reported quarter. The company’s earnings have lagged the Zacks Consensus Estimate in two of the trailing four quarters, with an average miss of 6.8%.

Let’s see how things are shaping up for this announcement.

What Does the Zacks Model Unveil?

Our proven model conclusively shows earnings beat for SUPERVALU this quarter. This is because a stock needs to have both a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) and a positive Earnings ESP for this to happen. You may uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

SuperValu Inc. Price, Consensus and EPS Surprise

SuperValu Inc. Price, Consensus and EPS Surprise | SuperValu Inc. Quote

SUPERVALU has an Earnings ESP of +24.64% with a Zacks Rank #3. This increases the predictive power of ESP, thus making us confident of an earnings beat.

Which Way are Estimates Treading?

Let’s look at the estimate revisions in order to get a clear picture of what analysts are thinking about the company right before earnings release.

The Zacks Consensus Estimate of 35 cents for the fiscal second quarter has been stable in the last 30 days while it reflects a year-over-year decline of about 50% from the year-ago quarter. However, the Zacks Consensus Estimate of $2.30 for fiscal 2018 shows 13.2% growth from fiscal 2017.

Further, analysts polled by Zacks expect revenues of $3,758 million for the impending quarter, down 2.8% from the year-ago quarter. Meanwhile, revenues of $15.50 billion are forecasted for fiscal 2018, thus showing an increase of 3.5% from fiscal 2017.

Factors Likely to Impact the Quarter

SUPERVALU is battling with its sluggish retail business for quite some time, owing to tough competitive pressure and lower store traffic. Evidently, the company has witnessed negative sales from identical retail stores for the last nine quarters. Additionally, the company is facing competition from traditional grocery rivals that are offering alternative outlets for food and other staples.

Further, revenues generated from existing transition services agreements with Albertson’s LLC and NAI, which are expected to wind-down over the next two years are anticipated to contribute to lower corporate sales and operating earnings in fiscal 2018. Consequently, SUPERVALU’s share price declined 26.9% in the last six months, wider than the industry’s loss of 7.4%.



Nevertheless, the company’s focus on accelerating business by making acquisitions and supply agreements in its wholesale segment remains noteworthy. These agreements are expected to boost its top line in fiscal 2018.

SUPERVALU is also trying to develop wholesale operations, primarily through adding new customers, retaining and developing business with existing customers and acquisitions. In fact, the acquisition of Unified Grocers is expected to boost the company’s wholesale business and complement its customer base.

Furthermore, the company has been shutting down its underperforming locations. This, in turn, will allow it to utilize its resources and investments on a few strong performing locations. Additionally, SUPERVALU has been striving to reduce cost and resorted to ‘single sourcing’ in its independent businesses in order to induce greater operating efficiency.

Stocks With Favorable Combination

Here are some companies you may want to consider as our model shows that these have the right combination of elements to post an earnings beat:

Nomad Foods Limited NOMD has an Earnings ESP of +8.70% and a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here.

Colgate-Palmolive Company CL has an Earnings ESP of +0.55% and a Zacks Rank #2.

The Procter & Gamble Company PG has an Earnings ESP of +0.77% and a Zacks Rank #2.

4 Stocks to Watch after the Massive Equifax Hack
 
Cybersecurity stocks spiked on recent news of a data breach affecting 143 million Americans. But which stocks are the best buy candidates right now? And what does the future hold for the cybersecurity industry?

Equifax is just the most recent victim. Computer hacking and identity theft are more common than ever. Zacks has just released Cybersecurity! An Investor’s Guide to inform Zacks.com readers about this $170 billion/year space. More importantly, it highlights 4 cybersecurity picks with strong profit potential.

Get the new Investing Guide now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
SuperValu Inc. (SVU): Free Stock Analysis Report
 
Procter & Gamble Company (The) (PG): Free Stock Analysis Report
 
Colgate-Palmolive Company (CL): Free Stock Analysis Report
 
Nomad Foods Limited (NOMD): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research]]>
http://so-l.ru/news/y/2017_10_13_is_a_beat_in_the_cards_for_supervalu_sv Fri, 13 Oct 2017 17:02:00 +0300
<![CDATA[The Zacks Analyst Blog Highlights: Danaher, Colgate-Palmolive, Facebook and Stanley Black & Decker]]>  For Immediate Release

Chicago, IL – October 12, 2017 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Danaher Corporation (NYSE:DHR Free Report), Colgate-Palmolive Company (NYSE:CL Free Report), Facebook, Inc. (NASDAQ:FB Free Report) and Stanley Black & Decker, Inc. (NYSE:SWK Free Report).

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.

Here are highlights from Wednesday’s Analyst Blog:

4 Stocks from 4 Top Sectors Set to Beat This Earnings Season

Time flies! We are already into the third-quarter 2017 reporting cycle, and as always, investors are gearing up to make most of earnings season.

Talking of making the most, we believe that diversification is one of the most successful investment strategies. That being said, we have brought to focus five solid S&P 500 stocks from five top-ranked Zacks sectors, which are likely to gain ground this earnings season. However, before getting into the stocks, let’s take a look at the picture painted so far and the expectations for the third quarter on the whole.

A Glimpse of Yesterday & Signals for Tomorrow

Per the latest Earnings Trends, 22 S&P 500 companies have reported financial numbers. Notably, 86.4% of these companies delivered an earnings beat, with 81.8% surpassing revenue estimates. Further, total earnings of these firms advanced 27.1% year over year, buoyed by a 7.3% jump in revenues. Clearly, the performance so far is nearly at levels with the second quarter, though it displays a considerable improvement when compared with the 4 and 12-quarter averages.

A glimpse at the overall expectations for the third quarter reveals that total earnings for the S&P 500 index is envisioned to rise 2.3%, with revenues likely to jump 5%. Also, major contributions of the earnings growth are expected to come from the Energy, Conglomerates and Technology sectors, out of which Energy and Conglomerates are anticipated to witness double-digit earnings growth.

Diversification a Win-Win Strategy:  5 Gems from 5 Solid Spaces

While the overall earnings growth in Q3 is expected to be lowest among all four quarters of 2017, the earnings season still offers good scope for investors, especially in some top-ranked Zacks sectors that are likely to witness year-over-year earnings and revenue growth. The sectors demanding attention are the Conglomerates, Consumer Staples, Technology and Industrial Products that are ranked among the top 13%, 19%, 25% and 31%, respectively out of all 16 classifications.

Here is the winning strategy: Plucking an S&P 500 stock from each top-ranked sector that possesses a favorable combination of Zacks Rank #1 (Strong Buy) or 2 (Buy) with a positive Earnings ESP. Our research shows that the chance of a positive earnings surprise is as high as 70% for stocks holding such a combination. You can uncover the best stocks to buy or sell before they’re reported with ourEarnings ESP Filter.

Here Are the Gems

Conglomerates (2 out of 16)
 
Expected Earnings Growth Rate in Q3 — 16.1%
Expected Revenue Growth Rate — 5.5%

Danaher Corporation(NYSE:DHR Free Report) is a global conglomerate that designs, manufactures and markets diverse lines of industrial and consumer products. With an Earnings ESP of +0.57%, the company is likely to beat earnings estimates when it posts third-quarter 2017 results on Oct 19.

Notably, this stock with a long-term earnings growth rate of 11.5% has surged 12.6% year to date, surpassing the sector’s 0.6% growth. Also, this Zacks Rank #2 company has a splendid positive earnings surprise history. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Consumer Staples(3 out of 16)

Expected Earnings Growth Rate in Q3— 1.7%
Expected Revenue Growth Rate — 2.2%

New York-based Colgate-Palmolive Company (NYSE:CL Free Report) is a viable bet from the Consumer Staples space. This Zacks Rank #2 company with a long-term growth rate of 8.6% hasn’t reported a single negative earnings surprise in the trailing four quarters. In fact, its favorable Earnings ESP of +0.55% makes us reasonably confident of an earnings beat, when Colgate reports results on Oct 27. Notably, this global consumer goods behemoth has jumped 13.3% so far this year, beating the sector’s 12.3% rise.

Technology(4 out of 16)

Expected Earnings Growth Rate in Q3— 9.7%
Expected Revenue Growth Rate — 6.7%

Facebook, Inc.(NASDAQ:FB Free Report) clearly remains strong in the technology space. This social media giant has topped earnings estimates in each of the trailing four quarters. Also, Facebook’s Zacks Rank #2 and Earnings ESP of +1.76% signal chances of the company to beat earnings yet again, on Nov 1. Facebook’s long-term growth rate of 24.5% and its marvelous stock performance is also worth noting. Evidently, shares of the company have soared 49.1% this year, crushing the sector’s solid growth of 23%.

Industrial Products(5 out of 16)

Expected Earnings Growth Rate in Q3— 8.7%
Expected Revenue Growth Rate — 2.7%

Stanley Black & Decker, Inc. (NYSE:SWK Free Report), which manufactures tools and engineered security solutions across the globe, has rallied 37.7% year to date, cruising the sector’s 18.4% growth. With a Zacks Rank #2 and an Earnings ESP of +2.09%, the company is likely to beat earnings estimates when it posts third-quarter 2017 results on Oct 24.

Notably, this New Britain-based company has a long-term earnings growth rate of 10.3%. The company’s robust earnings surprise record is a cherry on the cake.

Wall Street’s Next Amazon

Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.

Click for details >>

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1 Stock of the Day pick for free.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Strong Stocks that Should Be in the News

Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has nearly tripled the market from 1988 through 2015. Its average gain has been a stellar +26% per year.See these high-potential stocks free >>.

Get the full Report on DHR - FREE

Get the full Report on CL - FREE

Get the full Report on FB - FREE

Get the full Report on SWK - FREE

Follow us on Twitter: https://twitter.com/zacksresearch

Join us on Facebook: https://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

https://www.zacks.com/

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Facebook, Inc. (FB): Free Stock Analysis Report
 
Danaher Corporation (DHR): Free Stock Analysis Report
 
Stanley Black & Decker, Inc. (SWK): Free Stock Analysis Report
 
Colgate-Palmolive Company (CL): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research]]>
http://so-l.ru/news/y/2017_10_12_the_zacks_analyst_blog_highlights_danah Thu, 12 Oct 2017 15:29:00 +0300
<![CDATA[4 Stocks From 4 Top Sectors Set to Beat This Earnings Season (Revised)]]> Time flies! We are already into the third-quarter 2017 reporting cycle and as always, investors are gearing up to make most of the earnings season.

Talking of making the most, we believe that diversification is one of the most successful investment strategies. That said, we focus on four solid S&P 500 stocks from the four top-ranked Zacks sectors, which are likely to gain ground this earnings season. However, before getting into the stocks, let’s take a look at the picture painted so far and the expectations for the third quarter on the whole.

A Glimpse of Yesterday & Signals for Tomorrow

Per the latest Earnings Trends, 26 S&P 500 companies have reported financial numbers. Notably, 84.6% of these companies have registered a beat on both top and bottom-line front. Further, total earnings of these firms advanced 22.5% year over year, buoyed by a 9.4% jump in revenues. Clearly, the performance so far is nearly at levels with the second quarter, though it displays a considerable improvement when compared with the 4 and 12-quarter averages.

A glimpse at the overall expectations for the third quarter reveals that total earnings for the S&P 500 index is envisioned to rise 1.2%, with revenues likely to jump 5.1%. Also, major contributions of the earnings growth are expected to come from the Energy, Conglomerates and Technology sectors, out of which Energy and Conglomerates are anticipated to witness double-digit earnings growth.

Diversification a Win-Win Strategy:  4 Gems From 4 Solid Spaces

While the overall earnings growth in Q3 is expected to be lowest among all four quarters of 2017, the earnings season still offers good scope for investors, especially in some top-ranked Zacks sectors that are likely to witness year-over-year earnings and revenue growth. The sectors demanding attention are the Conglomerates, Consumer Staples, Technology and Industrial Products that are ranked among the top 13%, 19%, 25% and 31% out of all 16 classifications.

Here is the winning strategy: Plucking an S&P 500 stock from each top-ranked sector that possesses a favorable combination of Zacks Rank #1 (Strong Buy) or 2 (Buy) with a positive Earnings ESP. Our research shows that the chance of a positive earnings surprise is as high as 70% for stocks holding such a combination. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

Here are the Gems

Conglomerates (2 out of 16)
 
Expected Earnings Growth Rate in Q3 — 16.4%
Expected Revenue Growth Rate — 5.5%


Danaher Corporation DHR is a global conglomerate that designs, manufactures and markets diverse lines of industrial and consumer products. With an Earnings ESP of +0.57%, the company is likely to beat earnings estimates when it posts third-quarter 2017 results on Oct 19. Notably, this stock with a long-term earnings growth rate of 11.7% has surged 12.3% year to date, surpassing the sector’s 0.4% growth. Also, this Zacks Rank #2 company has a splendid positive earnings surprise history. You can see the complete list of today’s Zacks #1 Rank stocks here.

Consumer Staples (3 out of 16)

Expected Earnings Growth Rate in Q3 — 1.8%
Expected Revenue Growth Rate — 2.2%


New York-based, Colgate-Palmolive Company CL is a viable bet from the Consumer Staples space. This Zacks Rank #2 company with a long-term growth rate of 8.6% hasn’t reported a single negative earnings surprise in the trailing four quarters. In fact, its favorable Earnings ESP of +0.55% makes us reasonably confident of an earnings beat, when Colgate reports results on Oct 27. Notably, this global consumer goods behemoth has jumped 16.1% so far this year, beating the sector’s 12.3% rise.

Technology (4 out of 16)

Expected Earnings Growth Rate in Q3 — 9.7%
Expected Revenue Growth Rate — 6.7%


Online payment solutions provider, PayPal Holdings, Inc. PYPL is a clear winner in the technology space. This big-wig topped earnings estimates in the past two quarters. Also, PayPal’s Zacks Rank #1 and an Earnings ESP of +0.08% signal an earnings beat yet again, on Oct 19. PayPal’s long-term growth rate of 17.2% and marvelous stock performance are also worth noting. Evidently, shares of the company have soared 71.7% this year, crushing the sector’s solid growth of 23%.

Industrial Products (5 out of 16)

Expected Earnings Growth Rate in Q3 — 9.0%
Expected Revenue Growth Rate — 2.8%


Stanley Black & Decker, Inc. SWK, which manufactures tools and engineered security solutions across the globe, has rallied 38.3% year to date, cruising the sector’s 18.4% growth. With a Zacks Rank #2 and an Earnings ESP of +2.09%, the company is likely to beat earnings estimates when it posts third-quarter 2017 results on Oct 24. Notably, this New Britain-based company has a long-term earnings growth rate of 10.3%. The company’s robust earnings surprise record is the icing on the cake.

Wall Street’s Next Amazon

Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.

Click for details >>


(We are reissuing this article to correct a mistake. The original article, issued on Oct 11, 2017, should no longer be relied upon.)


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
PayPal Holdings, Inc. (PYPL): Free Stock Analysis Report
 
Danaher Corporation (DHR): Free Stock Analysis Report
 
Stanley Black & Decker, Inc. (SWK): Free Stock Analysis Report
 
Colgate-Palmolive Company (CL): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research]]>
http://so-l.ru/news/y/2017_10_12_4_stocks_from_4_top_sectors_set_to_beat Thu, 12 Oct 2017 13:51:00 +0300
<![CDATA[SunTrust sees upside for Colgate-Palmolive]]> http://so-l.ru/news/y/2017_10_11_suntrust_sees_upside_for_colgate_palmoli Wed, 11 Oct 2017 14:44:48 +0300 <![CDATA[Colgate-Palmolive stock price target raised to $85 from $65 at SunTrust RH]]> ]]> http://so-l.ru/news/y/2017_10_11_colgate_palmolive_stock_price_target_rai Wed, 11 Oct 2017 14:24:01 +0300 <![CDATA[Colgate-Palmolive upgraded to buy from hold at SunTrust RH]]> ]]> http://so-l.ru/news/y/2017_10_11_colgate_palmolive_upgraded_to_buy_from_h Wed, 11 Oct 2017 14:23:46 +0300